Roxadustat for treatment of anemia in a cancer patient with end-stage renal disease: A case report

Table 1 Laboratory data before blood transfusion

Parameter	Recorded value	Reference range
White blood cell count (× 109/L)	5.22	4.0-10.0
Red blood cell count (× 1012/L)	2.29	4.0-5.5
Hemoglobin (g/L)	65	120-160
Platelet count (× 109/L)	146	100-300
Hematocrit (%)	22	38.0-50.8
Mean corpuscular volume (fl)	95.9	80-100
Mean corpuscular hemoglobin (pg)	29.1	27-31
Mean corpuscular hemoglobin concentration (g/L)	304	320-360
Reticulocyte count (× 1012/L)	0.079	0.024-0.084
Reticulocyte percentage (%)	3.45	0.5-1.5
Iron (μmol/L)	7.68	10.6-36.7
Serum ferritin (μg/L)	345	30-300
Total iron binding capacity (μmol/L)	26.51	45-75
Transferrin saturation (%)	19.9	20-50
C-reactive protein (mg/L)	15.41	< 10
Albumin (g/L)	24.4	40.0-55.0
Calcium (mmol/L)	2.01	2.11-2.52
Phosphonium (mmol/L)	1.58	0.85-1.51
Intact parathyroid hormone (pg/ml)	27.3	150-300
Blood urea nitrogen (mmol/L)	21.66	3.6-9.5
Serum creatinine (μmol/L)	556	57.0-111.0
EPO concentration (mIU/ml)	28.6	4.3-29
Direct Coombs (IgG, C3) tests	Negative	Negative
Anti-EPO antibodies	Negative	Negative
Fecal occult blood test	Negative	Negative

EPO: Erythropoietin.